December 9, 2020 M&A, Partnerships Process Analytical Instr.

Sartorius acquires filtration expert WaterSep BioSeparations

Göttingen, December 9, 2020 Transaction provides a complementary fit with Sartorius’ separation portfolio, adding innovative crossflow filtration units for easy-to-use bioprocessing devices Technology is especially suited to gene and cell therapy applications, vaccine production and intensified bioprocessing  The life science company Sartorius today acquired U.S.‑based purification expert WaterSep BioSeparations LLC through its subgroup Sartorius Stedim Biotech.... Read more

December 9, 2020 M&A, Partnerships Process Analytical Instr. Product Launch

Activated Research Company Partners with Shimadzu Scientific Instruments to Offer Jetanizer

The world’s smallest methanizer now available for Shimadzu 2030 GCs Activated Research Company (ARC) is excited to announce that the Jetanizer is now available through Shimadzu Scientific Instruments (SSI) for Shimadzu GC-2030instruments. SSI will be offering the Jetanizer through its headquarters in Columbia, MD directly to end users in the US and to Shimadzu subsidiaries throughout... Read more

December 8, 2020 Other Lab Products/Services Product Launch

eNUVIO is Launching the EB-Plate

The first completely reusable 3D cell culture microplate on the market Caption: The first completely reusable 3D cell culture microplate on the market. To download image, please click here. Montreal, Canada, December 8th 2020 – Life Science Newswire – eNUVIO announced the release of the first completely reusable 3D cell culture microplate on the market. Scientific research currently consumes high-volumes of single-use... Read more

December 8, 2020 Clinical Research/Diagn. Licensing, IP, and Legal

Meridian Bioscience submits application to FDA for Emergency Use Authorization for SARS-CoV-2 molecular assay

December 8, 2020 at 10:17 AM EST CINCINNATI, Dec. 08, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has submitted its application for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for the company’s SARS-CoV-2 molecular diagnostic test on the Revogene® platform. The... Read more

December 8, 2020 Clinical Research/Diagn. Licensing, IP, and Legal

LGC’s Anti-SARS-CoV-2 controls kit now CE Marked

LGC is pleased to announce that the ACCURUN® Anti-SARS-CoV-2 Reference Material Kit is now CE marked for in vitro diagnostic use (CE-IVD). With this change in regulatory status, the new product name is ACCURUN Anti-SARS-CoV-2 Controls Kit. Bearing the CE mark and IVD symbol signifies that the ACCURUN Anti-SARS-CoV-2 Controls Kit meets extensive design control requirements. ACCURUN... Read more

December 3, 2020 Clinical Research/Diagn. Life Science Tools Product Launch

Meridian Launches its Novel Air-Dryable RT-qPCR Mix, Further Decreases Costs and Simplifies Workflows for COVID-19 Molecular Test Manufacturers

December 3, 2020 at 10:00 AM EST CINCINNATI, Dec. 03, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has launched an Air-Dryable RT-qPCR Mix, driving innovation in the development of molecular tests with ambient temperature stability. This specialized master mix is designed... Read more

December 2, 2020 Clinical Research/Diagn. M&A, Partnerships

Regulus Therapeutics Collaborates with Bio-Techne for Biomarker Development

MINNEAPOLIS, Dec. 2, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) and Regulus Therapeutics (NASDAQ: RGLS) announced a collaboration to support Regulus with biomarker analysis for the clinical development of RGLS4326, an Autosomal Dominant Polycystic Kidney Disease (ADPKD) treatment. Regulus has utilized two Bio-Techne branded product lines, ProteinSimple and Exosome Diagnostics, to aid in their clinical trial... Read more

December 2, 2020 Atomic Spectroscopy Product Launch

Agilent Announces New, Innovative 7850 ICP-MS System

Smart functions and tools optimize productivity and efficiency SANTA CLARA, Calif., December 02, 2020  Agilent Technologies Inc. (NYSE: A) today announced a new ICP-MS instrument, the Agilent 7850 ICP-MS System, that provides new smart tools to minimize common time traps that can affect ICP-MS analysis workflows.  Building on decades of innovation, the 7850 ICP-MS combines market-leading... Read more

December 1, 2020 Informatics & Software Life Science Tools Product Launch

New England Biolabs® Introduces NEBNext® Custom RNA Depletion Design Tool and RNA Depletion Core Reagent Set for Customizable RNA Depletion

Combination of free user-friendly web tool, to obtain custom probe sequences, and enzyme-based technology allows for efficient depletion of abundant RNAs for virtually any organism and sample type. IPSWICH, MA (December 1, 2020): Today, New England Biolabs (NEB®) announced further expansion of its RNA depletion product portfolio with the launch of the NEBNext Custom RNA... Read more

December 1, 2020 Cell Analysis Tools Clinical Research/Diagn. Product Launch

Miltenyi Biotec launches all-in-one kits for stimulation and analysis of SARS-CoV-2–reactive T cells

T cell activation an important parameter in COVID-19; linked to execution and control of multiple mediators in controlling infections1, 2 BERGISCH GLADBACH, December 1st – Miltenyi Biotec today launches new all-in-one kits for the efficient stimulation and functional analysis of SARS-CoV-2‒reactive T cells. Specifically developed for fast and rapid detection in PBMC samples after stimulation with the SARS-CoV-2... Read more